Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

US Healthcare Advertising Market | Trends and Industry Outlook 2017-2022

Healthcare advertising is becoming progressively important in the US so as to create awareness about various diseases along with the drugs and procedures required for their treatments. Owing to its growing need and increased government support, the US healthcare advertising market is expected to reach a value of US$ 447 Billion by 2021, growing at a CAGR of 1.5% during 2017-2021. To know more about market, click here: http://www.imarcgroup.com/us-healthcare-advertising-market

  • Identifiez-vous pour voir les commentaires

US Healthcare Advertising Market | Trends and Industry Outlook 2017-2022

  1. 1. Copyright © IMARC. All Rights Reserved US Healthcare Advertising Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021
  2. 2. IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results. Report DescriptionAbout IMARC Group
  3. 3. Report DescriptionReport Description and Highlights Growth of US Healthcare Advertising Market Driven by Introduction of New Drugs and Digital Transformation The US healthcare advertising market witnessed a positive growth owing to increasing direct-to- consumer (DTC) advertising and introduction of new drugs in market. As a result, the market is expected to grow at a CAGR of 1.5% during 2017-2021. According to IMARC Group’s new report, titled “US Healthcare Advertising: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021”, the US healthcare advertising market reached a value of US$ 407 Billion in 2016, growing at a CAGR of 4% during 2009-2016. With the rising number of new drugs launched in the market, the need to advertise these drugs and widen the consumer reach has also increased. Healthcare advertising is becoming progressively important in the US so as to create awareness about various diseases along with the drugs and procedures required for their treatments. Owing to its growing need and increased government support, the US healthcare advertising market is expected to reach a value of US$ 447 Billion by 2021, growing at a CAGR of 1.5% during 2017-2021. Read complete report with TOC: http://www.imarcgroup.com/us-healthcare-advertising- market
  4. 4. Report DescriptionReport Description and Highlights
  5. 5. Report Description Report Description and Highlights Highlights of the US healthcare advertising market: • Biopharmaceutical advertising sector represents the fastest growing segment. • Detailed advertising is the preferred channel of healthcare advertising. • Major pharmaceutical companies have started investing in DTC advertising, owing to increased competition in market. The US healthcare industry is digitally transforming with the introduction of electronic health records, telemedicine and remote medical monitoring system. Also, consumers and healthcare providers spend most of their time online on social networking sites. Therefore, digital advertising is steadily becoming an integral part of the US healthcare advertising market. Moreover, increasing presence of generic drugs has forced pharmaceutical companies to embrace new business strategies and advertise their products. The US healthcare advertising market is further boosted by government’s support to direct-to-consumer (DTC) advertising and increasing consumer reach through various digital platforms. Request for free sample report or more details, click here: http://www.imarcgroup.com/request?type=report&id=723&flag=B
  6. 6. Report DescriptionReport Description and Highlights Biopharmaceutical advertising market is the fastest growing segment, followed by over-the- counter drugs, vaccines and pharmaceuticals (small molecule drugs). Also, due to rising consumer demand for helpful and educational content in the form of blogs, social media, video and e-mails, the use of DTC channel is growing rapidly, but detailed advertising is still preferred over DTC advertising. Some of the major pharmaceutical companies investing in this sector include Johnson & Johnson, Pfizer, Merck & Co, GlaxoSmithKline, Novartis and Ely Lilly. The report by IMARC Group has examined the US Healthcare Advertising Market on the basis of: Product: • Pharmaceuticals (Small molecule drugs) • Biopharmaceuticals • Vaccines • Over-the-counter drugs Key Players:
  7. 7. Report DescriptionReport Description and Highlights • Johnson & Johnson • Pfizer • Merck & Co. • GlaxoSmithKline • Eli Lilly • Novartis • Sanofi • AstraZeneca • Roche • Bayer HealthCare • Bristol- Myers Squibb Browse more reports related to technology & media industry: http://www.imarcgroup.com/categories/technology-market-reports
  8. 8. Report DescriptionReport Description and Highlights © 2017 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
  9. 9. FOR MORE DETAILS Visit us at : Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com http://www.imarcgroup.com Contact Us

×